Dear Colleagues,
We welcome you to join the NTMnet webinar entitled "Therapeutic drug monitoring in nontuberculous mycobacterial disease: what you need to know?" on 29 of August at 17:00 CET in Zoom.
Please register for the webinar in advance using the link below:
After registering, you will receive a confirmation email containing information about joining the webinar.
Contact information: liga.r@tbnet.eu
Background
Are you navigating the complexities of treating NTM infections? With the lengthy and intricate multidrug regimens, potential for acquired resistance, and toxicity, achieving satisfactory treatment outcomes can feel like a walk in the dark. The lack of specifically developed agents and well-established pharmacokinetic and pharmacodynamic indices for NTM infections only adds to the challenge. Could therapeutic drug monitoring (TDM) be the beacon of light we need?
Join our expert in this enlightening webinar as we explore the role of TDM in the management of NTM infections.
Gain practical insights and learn how TDM might transform your approach to managing these challenging cases.
Speaker:
Rob Aarnoutse, PharmD, PhD
Associate professor, hospital pharmacist and clinical pharmacologist, Department of Pharmacy and Radboud Institute for Health Sciences at Radboud university medical center, Nijmegen, The Netherlands.
Chairs/moderators:
Natalie Lorent, MD, PhD
Consultant in Respiratory Medicine at University Hospitals Leuven, Professor of pneumology at KU Leuven, Belgium, Chair of NTM-NET.
Nils Wetzstein, MD
Consultant, Division of Infectious Diseases, University Hospital Frankfurt, Germany, Steering Committee NTM-NET.
Comments